Observational studyBreast cancer research and treatment2026

Translational and real-world evidence of trastuzumab biosimilar CT-P6 plus pertuzumab in neoadjuvant HER2-positive early breast cancer.

José Luis Alonso-Romero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.